一般財団法人未来医療推進機構
Osaka, Japan
Active| Registration number | T8120005021253 |
|---|---|
| Type | Corporation |
| Registered name | 一般財団法人未来医療推進機構 |
| Address | 大阪府大阪市北区中之島４丁目３番５１号ＮａｋａｎｏｓｈｉｍａＱｒｏｓｓ６階 NakanoshimaQross6階, 4-3-51 Nakanoshima, Osaka-shi Kita-ku, Osaka 530-0005, JAPAN |
| Corporate number | 8120005021253 |
| Corporate number assigned on | 2019-11-26 |
| Invoice registered on | 2023-10-01 |
| Record last updated | 2024-09-09 |
Invoice registration date = when the T-number took effect, not the founding date.
Corporate registry record
| Entity type | Other registered corporation |
|---|---|
| Reading (furigana) | ミライイリョウスイシンキコウ |
| Reading (romaji) | Miraiiryosuishinkiko |
| English name (unofficial) | Miraiiryosuishinkiko General Incorporated Foundation |
| Postal code | 530-0005 |
Source: NTA Corporate Number Publication Site, refreshed daily.
Timeline — registry changes
| 2024-04-24 | Head-office address changed (Japan) |
|---|
Source: daily change files of the NTA Corporate Number Publication Site. Before 2023-08-16 only the latest change is known. All company events →
Government contract awards (GEPS)
No public national-government (GEPS) award records for this company in the open data (FY2013 to date).
出典：調達ポータル（https://www.p-portal.go.jp/）
Payments from national budget programmes (行政事業レビュー)
Ministry review sheets report this company as a payee of 1 programme (1 lines, sheet years 2025–2025; total ¥286.7M).
| 2025 FY2024 | 再生・細胞医療・遺伝子治療の社会実装に向けた環境整備事業 ¥286.7M （経済産業省） 間接補助事業者：科学的・客観的データによって治療効果を確立し、再生・細胞医療・遺伝子治療の社会実装を推進する。 |
|---|
Contract details (excerpt): 未来医療国際拠点を中核とした、再生・細胞治療・遺伝子治療の基盤整備 ¥286.7M・補助金等交付 · bidders 9
Source: 行政事業レビュー見える化サイト (Cabinet Secretariat, PDL 1.0) — edited extract by LoreaTec. A sheet year describes the previous fiscal year’s spending. Programme database →
Verify in official sources
How to cite this page
Data via LoreaTec BizSearch (https://bizsearch.loreatec.jp/t8120005021253) — Source: National Tax Agency corporate-number and qualified-invoice registries. Retrieved 2026-09-25.
Reuse and AI use allowed with attribution. AI content licence